Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2016, Article ID 5960150, 4 pages
http://dx.doi.org/10.1155/2016/5960150
Case Report

Chronic Disseminated Candidiasis Complicated by Immune Reconstitution Inflammatory Syndrome in Child with Acute Lymphoblastic Leukemia

1Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznan, Poland
2Department of Pediatric Radiology, University of Medical Sciences, Poznan, Poland

Received 21 July 2016; Accepted 18 September 2016

Academic Editor: Kazunori Nakase

Copyright © 2016 Olga Zając-Spychała et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Karthaus, H. Hebart, H. Einsele et al., “Long-term survival in patients with acute leukemia and chronic disseminated candidiasis despite minimal antileukemic therapy,” Haematologica, vol. 91, no. 10, pp. 1422–1423, 2006. View at Google Scholar
  2. S. Sallah, R. C. Semelka, R. Wehbie, W. Sallah, N. P. Nguyen, and P. Vos, “Hepatosplenic candidiasis in patients with acute leukaemia,” British Journal of Haematology, vol. 106, no. 3, pp. 697–701, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Chaussade, F. Bastides, S. Lissandre et al., “Usefulness of corticosteroid therapy during chronic disseminated candidiasis: case reports and literature review,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 6, Article ID dks044, pp. 1493–1495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Antachopoulos and T. J. Walsh, “New agents for invasive mycoses in children,” Current Opinion in Pediatrics, vol. 17, no. 1, pp. 78–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Murdoch, W. D. F. Venter, A. Van Rie, and C. Feldman, “Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options,” AIDS Research and Therapy, vol. 4, article 9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. P. Kontoyiannis, M. A. Luna, B. I. Samuels, and G. P. Bodey, “Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis,” Infectious Disease Clinics of North America, vol. 14, no. 3, pp. 721–739, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Pagano, L. Mele, L. Fianchi et al., “Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes,” Haematologica, vol. 87, no. 5, pp. 535–541, 2002. View at Google Scholar · View at Scopus
  8. F. Legrand, M. Lecuit, B. Dupont et al., “Adjuvant corticosteroid therapy for chronic disseminated candidiasis,” Clinical Infectious Diseases, vol. 46, no. 5, pp. 696–702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. V. C. C. Cheng, K.-Y. Yuen, W.-M. Chan, S. S. Y. Wong, E. S. K. Ma, and R. M. T. Chan, “Immunorestitution disease involving the innate and adaptive response,” Clinical Infectious Diseases, vol. 30, no. 6, pp. 882–892, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Bicanic, T. Harrison, A. Niepieklo, N. Dyakopu, and G. Meintjes, “Symptomatic relapse of HIV-associated cryptococcal meningitis after initial huconazole monotherapy: the role of fluconazole resistance and immune reconstitution,” Clinical Infectious Diseases, vol. 43, no. 8, pp. 1069–1073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. French, B. G. Oliver, J. H. Elliott, and P. Price, “Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome,” AIDS, vol. 25, no. 13, pp. 1676–1677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Masood and S. Sallah, “Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment,” Leukemia Research, vol. 29, no. 5, pp. 493–501, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Patel, “Antifungal agents. Part I. Amphotericin B preparations and flucytosine,” Mayo Clinic Proceedings, vol. 73, no. 12, pp. 1205–1225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. N. D. Grover, “Echinocandins: a ray of hope in antifungal drug therapy,” Indian Journal of Pharmacology, vol. 42, no. 1, pp. 9–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. L.-M. Poon, H.-Y. Chia, L.-K. Tan, T.-C. Liu, and L.-P. Koh, “Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature,” Transplant Infectious Disease, vol. 11, no. 2, pp. 160–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Imahashi, Y. Inamoto, A. Seto et al., “Impact on relapse of corticosteroid therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia,” Clinical Transplantation, vol. 24, no. 6, pp. 772–777, 2010. View at Publisher · View at Google Scholar · View at Scopus